- Home
- TXMD vs DFLI Comparison
TXMD vs DFLI Comparison
Compare TXMD & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- DFLI
- Stock Information
- Founded
- TXMD 2008
- DFLI 2020
- Country
- TXMD United States
- DFLI United States
- Employees
- TXMD N/A
- DFLI N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- DFLI Electronic Components
- Sector
- TXMD Health Care
- DFLI Technology
- Exchange
- TXMD Nasdaq
- DFLI Nasdaq
- Market Cap
- TXMD 12.7M
- DFLI 14.5M
- IPO Year
- TXMD N/A
- DFLI N/A
- Fundamental
- Price
- TXMD $1.07
- DFLI $0.28
- Analyst Decision
- TXMD
- DFLI Strong Buy
- Analyst Count
- TXMD 0
- DFLI 1
- Target Price
- TXMD N/A
- DFLI $1.50
- AVG Volume (30 Days)
- TXMD 17.2K
- DFLI 24.5M
- Earning Date
- TXMD 08-12-2025
- DFLI 08-14-2025
- Dividend Yield
- TXMD N/A
- DFLI N/A
- EPS Growth
- TXMD N/A
- DFLI N/A
- EPS
- TXMD N/A
- DFLI N/A
- Revenue
- TXMD $2,559,000.00
- DFLI $54,536,000.00
- Revenue This Year
- TXMD $427.09
- DFLI $28.01
- Revenue Next Year
- TXMD N/A
- DFLI $43.54
- P/E Ratio
- TXMD N/A
- DFLI N/A
- Revenue Growth
- TXMD 156.93
- DFLI 4.80
- 52 Week Low
- TXMD $0.70
- DFLI $0.15
- 52 Week High
- TXMD $2.44
- DFLI $5.78
- Technical
- Relative Strength Index (RSI)
- TXMD 42.48
- DFLI 46.63
- Support Level
- TXMD $1.05
- DFLI $0.28
- Resistance Level
- TXMD $1.12
- DFLI $0.31
- Average True Range (ATR)
- TXMD 0.04
- DFLI 0.03
- MACD
- TXMD -0.00
- DFLI -0.00
- Stochastic Oscillator
- TXMD 15.46
- DFLI 13.39
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About DFLI Dragonfly Energy Holdings Corp. (NV)
Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.